Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
These numbers are lower than the clinical trials because real-world patients are less adherent, have more comorbidities, and may not reach the maximum dose
Erythromycin as a motilin receptor agonist shows promise but faces limitations from tachyphylaxis and drug interactions [63]
Dose adjustments may be required to minimize adverse outcomes
Compound Specifications CAS 170851-70-4 MW 711.85 Da Purity 99.524% Documentation & Lab Use Form: Lyophilized research material Documentation: Review the product label, batch records, and applicable laboratory SOPs before accessioning
It is prepared and shipped by FDA-registered, inspected compounding pharmacies
US$ 24.65
US$ 29.87
US$ 25.18
US$ 27.33
US$ 21.61
US$ 29.39
US$ 26.90
US$ 1046.97
Sold : Login>>